Pharmaceutical policy is sometimes driven by limited data. |
Our aim was to fill an important gap in the difference between list and net pharmaceutical expenditure in the EU5 and describe how that difference might evolve in the near future. |
Available data indicate that the list versus net pharmaceutical expenditure gap is significant and increasing. |
Our results suggest that pharmaceutical expenditure is under control, below predicted healthcare expenditure growth in Europe, and in line with long-term economic growth rates. |